The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects

NCT06148389 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immune Thrombocytopenia

Interventions

DRUG: STSA-1301 subcutaneous injection
DRUG: Placebo

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd